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Abstract. A functionalized paramagnetic manganite La0.33Ca0.67MnO3 was investigated for its 
morphological, optical and antimicrobial properties. The manganite was capped by using a 
citrate ligand. The UV-visible spectrophotometer was used in monitoring the optical bands of 
the metal-citrate complex. It was observed to absorb in the visible region. The metal-citrate was 
reacted with a biologically active ligand (N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido) 
propanamide). The optical bands observed from the metal-citrate were used in monitoring the 
reaction between the metal-citrate and N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido) 
propanamide). The morphological property of the product formed was determined using SEM-
EDAX. The effect of the complex formed on the organic ligand, N-(3-nitrophenyl)-3-phenyl-2-
(phenylsulfonamido) propanamide) was determined using 1H and 13C NMR. The bacterial 
inhibitory property of the metal-citrate- N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido) 
propanamide) complex was determined against Pseudomonas aeruginosa and Staphylococcus 
auerus. It was observed to inhibit the growth of Staphylococcus aureus only. The biological 
activities of the metal-citrate N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido) propanamide) 
suggest its use as an alternative antibacterial therapy. 
Keywords: Pseudomonas aeruginosa, Staphylococcus aureus, Functionalization, Manganite 
and Nanoparticles 
1. Introduction 
Nanoparticle in recent times has been indispensably used in medicine and biotechnology in drug delivery 
and bactericidal drugs [1-3]. Nanomedicine introduces an approach to overcome challenges of recent 
traditional drug delivery systems based on the synthesis, development, fabrication and modification of 
nanostructures. There are various types of nanoparticle systems that  have been tried as potential drug 
delivery systems including, metal containing nanoparticles, biodegradable polymeric nanoparticles [4], 
nanogels, solid lipid nanoparticles (SLN), nanoliposomes [5]. 
Functionalization of nanoparticles is a very important phenomenon that defines its use in 
nanomedicine. Functionalized nanoparticles have been attested to have multifunctional properties that 
enhance its efficacy in various treatments such as cancer therapy [6], drug delivery [7], magnetic 
resonance imaging [8] etc. The surface of nanoparticles has been covalently bonded to small molecules 
which include small biocompatible ligands, dyes and silica [9]. PEG coated gold nanorods have been 
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used for murine tumor tissues by passive targeting mechanism [10]. Manganites have been famous for 
their ability to be easily modified, despite their various properties and uses the ability to use them in 
biomedicine has been very limited, hence, the functionalization of the nanoparticles [11]. Although the 
surface of manganites have been modified using a number of ligands and used in detection [12] and 
treatment of various diseases [13], however to date no attempt has been made to functionalize 
manganites using a sulphonamide despite the fact that they are known antibacterial agents, the use of 
manganites gives the opportunity for target therapeutic drug delivery to infested cells. 
Therefore, this research focuses on the functionalization La0.33Ca0.67MnO3 using N-(3-
nitrophenyl)-3-phenyl-2-(phenylsulfonamido)propanamide as the organic ligand to improve the 
antimicrobial activity of the functionalized nanoparticle against Pseudomonas aeruginosa and 
Staphylococcus aureus. 
2. Materials and Methods 
La2O3, CaCO3, MnCO3, trisodium citrate, ethylene glycol, citric acid and phosphate buffer were 
obtained from Sigma-Adrich (USA) and they were used without further purification. The ligand, N-(3-
nitrophenyl)-3-phenyl-2-(phenylsulfonamido)propanamide was used as synthesized by Ajani et al. [14]. 
2.1. Synthesis of La0.33Ca0.67MnO3 
Manganites were prepared using the sol gel method as described by Iniama et al. [15]. In preparing the 
manganite, 6.25 mmol of La2O3 powder (1.357 g) was dissolved in 50 ml nitric acid.  25 mmol MnCO3 
(2.8738 g), 12.5 mmol CaCO3 (1.682 g) and 10 g of citric acid monohydrate and 10 ml of ethylene glycol 
were used in the preparation. The sol gel process of synthesis was followed to yield a dark brown 
powder. The powder was heated in the furnace at 600ºC for 24 hours and consecutive sintering continued 
at 900ºC for two hours. 
The proposed equation of reaction based on the precursors used is as described below: 
 2367.033.03332
3
2
6
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COMnOCaLaMnCOCaCOOLa
 
The structural and morphological properties (elemental composition) of the manganite were 
determined using X-ray Diffractometer (Cu Kα - radiation, PANalytical X’pert Pro MPD diffractometer 
λ= 1.54056 Å) and JEOL JSM 6400 Scanning Electron Microscopy with magnifications 3000-20,000x 
coupled to an Energy dispersive X-ray Spectroscopy, respectively. 
2.2. Synthesis of citrate capped-LCMO-N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido) 
propanamide 
Trisodium citrate dihydrate, ethanol 99% purity was used as purchased from Sigma Aldrich. All the 
aqueous solutions were prepared by using a 10mM phosphate buffer solution with pH~7. The trisodium 
citrate dehydrate was dissolved in 100 mL buffer solution. The funtionalized nanoparticle was 
synthesized by methods as described by Giri et al. [13]. 
The manganites were rendered soluble by dissolving in a 30 mL of the citrate solution and stirred 
extensively for 4 hours. The un-reacted nanoparticles were filtered out and the optical properties of the 
resulting greenish yellow solution was determined using UV-visible Spectrophotometer (Genesys 30 
visible spectrophotometer). The N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido)propanamide was 
dissolved in 30 mL of analytical grade ethanol (99% purity). The manganite solution was stirred 
vigorously for an hour at room temperature to form a homogenous solution. Afterwards, 30 mL of the 
ligand solution was divided into five aliquots and added to the manganite solution while stirring. The 
mixture was stirred for about two hours to attain homogeneity of the solution while monitoring with 
Thin Layer Chromatography (TLC) flexible plates and UV-visible spectrophotometer. The beaker 
containing the solution was covered with perforated aluminium foil and left undisturbed for 14 days for 
the crystals to grow. The products were filtered out after 14 days and the recovered products were dried 
and weighed to obtain the percentage yield thereof. 13C and 1H NMR and SEM-EDS were used in 
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characterization of the sample. The melting point of both N-(3-nitrophenyl)-3-phenyl-2-
(phenylsulfonamido)propanamide and citrate capped LCMO-N-(3-nitrophenyl)-3-phenyl-2-
(phenylsulfonamido)propanamide were determined. 
2.3.  Antimicrobial properties of the synthesized complex 
Prior to the analysis the sample was dissolved in a universal solvent (Dimethyl sulphoxide) (DMSO).The 
zone of inhibition of the dissolved sample was determined by using the well diffusion method as 
described by [16, 17]. Nutrient agar was used to sub-culture the microorganisms. The agar was heated 
so as to convert it to liquid state after which it was cooled to 50ºC in a water bath. Streaks of the 
Staphylococcus aureus (ATCC 25923) and Pseudomonas aeruginosa (ATCC 1544) was put into the 
agar and left alone to set.  The petri dish was put in an incubator for 24 hours at 37ºC. Holes of about 
5mm to the edge of the plates were drilled into the petri dishes by using a sterile cock borer. 300 mg/mL 
of the dissolved solution was inoculated into the perforated well using a micro pipette. The petri dish 
was pre-diffused for 30 minutes and kept in an incubator for 24 hours at 37ºC, until an obvious reduction 
of the potency of the complex was observed. The zone of inhibition of the sample was determined in 
mm.10 µg/disc of an antibacterial drug (gentamicin) was used as control. 
3. Result and Discussions 
3.1. Structural Properties of LCMO 
The structural properties of the samples were determined by means of XRD (Fig 1), it was indexed to a 
perovskite-like structure. The average crystallite size (ΔD) was calculated by using Scherer’s formula 
(Scherer, 1918; Ehi-Eromosele et al., 2018). 
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The powder x-ray diffraction study showed that most of the sample has a single perovskite phase 
with identifiable peaks, indexed to the Pnma space group, orthorhombic crystallite structure. The 
average crystal size was determined as 15.3 nm. 
 
Figure 1. XRD patterns of La0.33Ca0.67MnO3 
sintered at 900ºC. 
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3.2. Morphological properties 
The SEM images shown in Figs. 2 (a) – (b) indicated that the manganite was homogenous with the 
presence of highly porous spherical-like particles. This might be due to the method of preparation (sol 
gel), which evolved a large amount of gases on ignition. The average elemental composition of the 
manganite was determined to be La0.32Ca0.68Mn0.97O3. The difference between the nominal composition 
and the elemental composition might be due to the errors incurred during synthesis of sample. 
 
Figure 2. (a) SEM micrograph of LCMO (b) Energy dispersive spectroscopy of 
showing the elemental composition of LCMO. 
3.3. Physical properties of the precursors (citrate capped-LCMO and N-(3-nitrophenyl)-3-phenyl-2-
(phenylsulfonamido) propanamide) and the product citrate capped-LCMO-N-(3-nitrophenyl)-3-phenyl-
2-(phenylsulfonamido) propanamide 
The physical properties of the sample are as described in Table 1. The difference in the melting point of 
the product and the precursor indicates that a new sample was formed when the citrate capped LCMO 
reacted with N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido) propanamide. 
Table 1. Physical properties of citrate capped- LCMO, N-(3-nitrophenyl)-3-phenyl-2-
(phenylsulfonamido) propanamide and citrate capped-LCMO-N-(3-nitrophenyl)-3-phenyl-2-
(phenylsulfonamido) propanamide. 
3.4. Spectroscopic analysis of the product citrate capped-LCMO-N-(3-nitrophenyl)-3-phenyl-2-
(phenylsulfonamido) propanamide 
3.4.1 1H-NMR and 13C-NMR. In view of ensuring that the capped LCMO has indeed been functionalized 
by the ligand N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido) propanamide, 13C-NMR and 1H-NMR 
were performed in view of determining the alterations that the nanoparticle would induce on its organic 
ligand. Figs. 3 (a) and (b) show the 13C-NMR 1 and H-NMR, respectively. 
1H-NMR (400 MHz, DMSO-d6) δH: 11.09(s, 1H, NH, NH-CO), 8.41-8.39 (d, J = 8.28 Hz, 2H, Ar-
H), 8.11-8.04 (dd, J=8 Hz, J2=28 Hz, 1H, Ar-H), 7.95-7.92 (d, J=9.42Hz, 2H, Ar-H), 7.81-7.78 (m, 1H, 
Ar-H), 7.65-7.63 (d, J = 7.84 Hz, NH-H), 7.54-7.52(m, 1H, Ar-H), 7.21 (s, 5H, Ar-H), 7.12-7.08 (m, 
1H, Ar-H), 3.45-3.40 (q, J = 7.00 Hz, NH-CH-CH2), 2.10-2.07(d, J = 10.24 Hz, CH2-CH). 
Precursor Appearance Texture Melting Point (ºC) 
Citrate Capped- LCMO Greenish yellow Solution - 
N-(3-nitrophenyl)-3-phenyl-2-
(phenylsulfonamido) propanamide 
Dark orange Powder 172 
Citrate Capped-LCMO-N-(3-nitrophenyl)-3-
phenyl-2-(phenylsulfonamido) propanamide 
Yellow Paste 115 
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13C-NMR (400MHz, DMSO-d6) δC: 168.9 (C=O), 154.8, 147.9, 141.3 (2 X CH), 135.0, 134.4, 134.2, 
132.1 (2 X CH), 120.3, 116.9, 25.4 (CH2), 24.2 (CH3) ppm. 
The 1H-NMR and 13C-NMR of the compounds were run in DMSO-d6, the broad shift observed at 
4.72 is appropriated to the D2O, which was used in synthesis of samples. The proton singlet at 7.21 was 
due to the presence of 5 aromatic protons neighbouring a CH. The suppression of the quartet at 3.45-
3.40 might be due to the neighbouring interference of the paramagnetic manganite attached at that site.  
The 13C-NMR was run at 400 MHz using a deuterated DMSO –d6 as the solvent. It shows that the 
presence of 21 carbon atoms with dc ranging from 168.9-24.2, this was made up of aromatic carbons, 
one aliphatic carbon and one carbonyl group. 
3.4.2. Ultraviolet-visible Spectroscopy. Fig. 4 shows the UV-visible spectroscopy of capped LCMO-N-
(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido) propanamide and also bare N-(3-nitrophenyl)-3-
phenyl-2-(phenylsulfonamido) propanamide. The distinct difference between the peaks observed at Fig 
3(a) and 3(b) is indicative of the fact that a manipulation had occurred in the ligand. Two broad bands 
observed at 205 nm and 277 nm were observed in the spectra of the capped LCMO-N-(3-nitrophenyl)-
3-phenyl-2-(phenylsulfonamido) propanamide while broad bands of 205 nm and 232 nm were observed 
in the spectrum of bare N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido) propanamide, The peaks 
around 232 nm is assigned to be the π      π*   transition associated with the presence of a benzenoid ring 
(Ajani et al., 2016).  The blue shift and broadening of peak at 277 nm might be due to the complex 
formed between the metal and the N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido)propanamide. The 
similarity in the wavelength observed for both samples might be indicative of the fact that the 
dominating unit in the complex is the N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido)propanamide 
unit. 
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Figure 3. (a) 13C-NMR (b) 1H-NMR of LCMO-N-(3-
nitrophenyl)-3-phenyl-2- (phenylsulfonamido)propanamide. 
 
Figure 4. Ultraviolet-visible spectral of (a) NPPA (b) (N-(1-((3-nitrophenyl)amino)-1-oxo-3- 
phenylpropan-2-yl)phenylsulfonamide) manganese. 
(a) (b)
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3.5. Morphological property of citrate capped-LCMO-N-(3-nitrophenyl)-3-phenyl-2-
(phenylsulfonamido) propanamide 
The morphological property of the product was determined by using SEM. Fig. 5 shows the SEM 
micrograph of the sample. The morphology of the surface of the sample indicates a film of polymeric 
aggregation. Although it is known that due to the fact that manganite (LCMO) is a stable compound in 
aqueous solutions of pH ≤ 6 with no modifications to its initial formulation [13], therefore the film of 
polymeric aggregation observed on the surface of the metal-citrate nanopartile may be due to the change 
in the change in the structural formulation of the ligand due to the complex formed with the 
nanoparticles. 
 
Figure 5. Ultraviolet-visible spectral of LCMO-N-
(3-nitrophenyl)-3-phenyl-2-phenylsulfonamido) 
propanamide. 
3.6. Antimicrobial analysis of capped LCMO- N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido) 
propanamide 
The sensitivity test (zone of inhibition, mm (ZOI)) of the synthesized complex was determined using 
the well diffusion method [16]. The two organisms used in this in vitro antibacterial analysis were 
Staphylococcus aureus, (gram positive) and Pseudomonas aeruginosa (gram negative). From the result 
obtained, the activities of the complex on the test organisms were classified based on the size of zone of 
inhibition. It was observed that the product was significantly active with remarkable zone of inhibition 
against (Staphylococcus aureus) with ZOI of 14 nm, and no zone of inhibition against Pseudomonas 
aeruginosa. The resistance of  Pseudomonas aeruginosa may be due to reduced cell wall permeability 
of LCMO-N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido)propanamide. 
4. Conclusion 
Manganite, La0.33Ca0.67MnO3 was synthesized at 900ºC using sol gel method. The morphological 
properties of the resulting brown powder was determined using SEM and TEM. The manganite was 
capped using citrate and functionalized using N-(3-nitrophenyl)-3-phenyl-2-(phenylsulfonamido) 
propanamide. Optical spectrophotometer (UV-Visible) was used in determining the optical bands of the 
functionalized sample. Surface morphology of the functionalized sample was determined using SEM. 
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1H-NMR and 13C-NMR was utilized in determining the alterations of the chemical shifts due to 
functionalization with the organic ligand. The antibacterial properties of the sample was done against 
Staphylococcus aureus and Pseudomonas aeruginosa, it was active against Staphylococcus aureus only. 
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